PPT-Pharmacist Models of Buprenorphine Care

Haley Pals PharmD BCPP Tomah VA Medical Center Tomah WI ECHO January 6 th 2022 Objectives Recognize the possible routes of training for pharmacists Identify various established buprenorphine collaborations. Kylie Reed . a,b. ,. Karolina . Bogdanowicz. . b, . James Bell . a,b. , . Rob . VanderWaal. . a, . Jenny Keen . a,b. , . Pete . Beavan. . a. , Shelagh Baillie . c, . Alastair Knight . d, . John . Krystalyn Weaver, PharmD. VP, Policy & Operations. National Alliance of State Pharmacy Associations. Disclosure. I . do not have (nor does any immediate family member have) actual or potential conflict of interest, within the last twelve months; a vested interest in or affiliation with any corporate organization offering . ?. Dr Nick Bray, Chairman, Somerset LMC. The Current NHS contracting and Commissioning arrangements are no longer fit for purpose as society has changed so much since 1948 . Demand Drivers. Demographic change. Treatment (MAT):. Problem . or Solution?. Quintin Thomas Chipley, M.A., M.D., Ph.D.. a. nd. Greg Jones, M.D., ABFM, ABAM, MRO. Prepared for CAPTASA 2016. DISCLOSURES. Neither presenter has any financial interest in any mode of treatment as discussed in this presentation.. Medication . Assisted Treatment, . Team Training, and Resources. PRIMARY CARE PRACTICE TEAM TRAINING. Module 4. Special Populations. Copyright 2018 Regents of the University of Colorado.  All Rights . Jaye M Shyken, MD. St Louis University School of Medicine. Oct 3, 2018. I Have No Financial Conflict of Interest to Report. 2017 Opioid Addiction in the US. In 2016, 11.8 million Americans age 12 or older misused opioids (4.4%). Julie Kmiec, DO. Assistant Professor of Psychiatry. University of Pittsburgh. kmiecj@upmc.edu. April 10, 2018. 1. Objectives. Review prevalence of opioid use disorders. Discuss the unmet needs for those with OUD. As illicit fentanyl has become a predominant opioid of abuse in New Mexico and many areas of the United States. Buprenorphine induction is becoming more difficult with women having trouble tolerating the withdrawal required to initiate buprenorphine and then having prolonged withdrawal despite buprenorphine titration. I. Yousef Ahmed Alomi, Manal El-Bahnasawi, Alaa Elemam, Tasneem Shaweesh, Edmarie Janine Antonio. Objectives:. . The study aims to explore the economic outcomes of the clinical pharmacist at critical care units at a private hospital in Riyadh city, Saudi Arabia in a 6 month study and prevent additional medication costs.. Faisal Al-. Otaibi. , Mohamed . Soliman. Imam, . Randa. Mansour Abdel-. Sattar. Ahmed, . Amsha. . Alotaibi. , . Asma. . Alotaibi. , . Amal. . Alotaibi. , . Wesam. . Alsuwaid. , Yousef Ahmed . Alomi. Kaylin A . Klie. , MD, MA, FASAM. Addiction Medicine. University of Colorado and Denver Health. ICWB Shared Learning. March 28. th. , 2022. Discussion Today:. Low Dose Buprenorphine Initiation Strategies. Isaac Marsolek MD. Procedural sedation and . Bupe. How should patients be managed?. Difference for procedures with local anesthetic vs without local anesthetic?. Disclaimer. Isaac Marsolek. What is the issue?. Eric Wenzler. 1. , . Fei.  Wang. 2. , . Debra . Goff. 2. , Beth Prier. 2. , John Mellett. 2. , Julie Mangino. 3. , and Karri A. Bauer. 2. 1. College of Pharmacy, University of Illinois at Chicago; Departments of . Tim Furnish, MD. Clinical Professor. UC San Diego Health. August . 2023. Disclosures. Fellowship Educational Grants: . Medtronic, Abbott, Boston Scientific, Nevro. Buprenorphine. Buprenorphine. FDA Indications, uses, and legal distinctions.